Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
11/2013
11/07/2013US20130296303 Spiro-oxindole mdm2 antagonists
11/07/2013US20130296298 Triazolopyridazine compounds, use as inhibitors of the kinase lrrk2, and methods for preparation thereof
11/07/2013US20130296295 Bcl-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases
11/06/2013EP2658859A2 Macrocyclic hepatitis c serine protease inhibitors
11/06/2013EP2658858A2 Phenanthridine macrocyclic hepatitis c serine protease inhibitors
11/06/2013EP2658379A1 Arthropod pest control composition and method for controlling arthropod pests
11/06/2013CN1856572B Use of RNAi inhibiting PARP activtiy for the manufacture of a medicament for the treatment of cancer
11/06/2013CN103384671A Compounds having indolocarbazole ring structure, and organic electroluminescent elements
11/06/2013CN103384670A Substituted imidazo[1,2-b]pyridazines
11/06/2013CN103383990A Application of 6-aza-benzophenanthrene derivative to organic light-emitting element
11/06/2013CN103382205A Bone-targeting zinc phthalocyanine and its preparation method and use
11/06/2013CN102617581B 58Fe hemin, preparation method and application of 58Fe hemin to study of pharmacokinetics
11/06/2013CN102503829B Preparation methods for sitagliptin intermediates
11/06/2013CN102408430B Synthetic process and special equipment for substituted bis [tetraphenylporphinatoiron]
11/06/2013CN102378739B Method for preparing cha-type molecular sieves using novel structure directing agents
11/06/2013CN102260269B Dendrimer containing porphyrin or chlorine and its application
11/06/2013CN102180884B Preparation and application of one-class meso-position-tetra (phenyl-1,3-butadiyne) porphyrin-zn coordination complex derivative
11/06/2013CN101772475B Process for the resolution of zopiclone and intermediate compounds
11/06/2013CN101448822B Substituted pyrazolopyrimidines
11/06/2013CN101273042B Macrocyclic inhibitors of hepatitis C virus
11/05/2013US8575360 Derivatives of 6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-carboxylic acid amides
11/05/2013US8575337 Oxazolidinone derivative having fused ring
11/05/2013US8575336 Indazoles
11/05/2013US8575179 Dihydropyrazolopyrimidinone derivatives
11/05/2013US8575178 Isothiazolo-pyrimidinedione derivatives as TRPA1 modulators
11/05/2013US8575177 Pyrazolopyrimidines and related heterocycles as CK2 inhibitors
11/05/2013US8575165 Methods for treating inflammatory disorders using 2,4-pyrimidinediamine compounds
11/05/2013US8575160 Imidazole derivatives as aldosterone synthase inhibitors
11/05/2013US8575149 5HT2C receptor modulators
10/2013
10/31/2013WO2013163279A1 Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation
10/31/2013WO2013163241A1 Imidazothiadiazole and imidazopyridazine derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation
10/31/2013WO2013163239A1 Synthesis of lactams
10/31/2013WO2013163130A1 Methods for producing 1,5,7-triazabicyclo[4.4.0] dec-5-ene by reaction of a disubstituted carbodiimide and dipropylene triamine
10/31/2013WO2013162061A1 Bicyclic pyrimidine compound
10/31/2013WO2013162040A1 Cyclic quaternary ammonium salt, nonaqueous solvent, nonaqueous electrolyte, and power storage device
10/31/2013WO2013161853A1 Quinazolinedione derivative
10/31/2013WO2013161851A1 Benzamide derivative
10/31/2013WO2013159698A1 Fused ring quinazoline hydroximic acid compound and use thereof as anti-tumour drug
10/31/2013WO2013159224A1 2-carbamo(thio)yl-1,3- dioxopropyl derivatives in cancer therapy
10/31/2013WO2013124701A3 Homo- and heterodimeric smac mimetic compounds as apoptosis inducers
10/31/2013WO2013111118A3 Diaziridines for treating neurodegenerative disorders
10/31/2013WO2013111117A3 Diaziridines for treating neurodegenerative disorders
10/31/2013US20130289276 Process for preparing an intermediate of sitagliptin via enzymatic conversion
10/31/2013US20130289273 Methods for producing 1,5,7-triazabicyclo[4.4.0]dec-5-ene by reaction of a disubstituted carbodiimide and dipropylene triamine
10/31/2013US20130289272 Methods for producing 1,5,7-triazabicyclo[4.4.0]dec-5-ene by reaction of a disubstituted carbodiimide and dipropylene triamine
10/31/2013US20130289271 PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY
10/31/2013US20130289042 Dimeric iap inhibitors
10/31/2013US20130289040 MALEATE SALTS OF 6-(5-CHLORO-2-PYRIDYL)-5-[(4-METHYL-1-PIPERAZINYL)CARBONYLOXY]-7-OXO-6,7-DIHYDRO-5H-PYRROLO[3,4-b]PYRAZINE
10/31/2013US20130289039 Besylate Salts of 6-(5-Chloro-2-Pyridyl)-5-[(4-Methyl-1-Piperazinyl)Carbonyloxy]-7-oxo-6,7-dihydro-5H-Pyrrolo[3,4-b]Pyrazine
10/31/2013US20130289038 2-arylimidazole derivatives as pde10a enzyme inhibitors
10/31/2013US20130289037 Inhibitors of e1 activting enzymes
10/31/2013US20130289036 Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
10/31/2013US20130289031 Pyrimidinone derivatives, preparation thereof and pharmaceutical use thereof
10/31/2013US20130289017 5 (1,2,3-triazol-4-yl)-7h-pyrrolo[2,3-d]pyrimidine derivatives
10/31/2013US20130289016 Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
10/31/2013US20130289013 IMIDAZO[1,2-a]PYRIDINE COMPOUNDS
10/31/2013US20130287789 Organic Compounds
10/31/2013US20130287730 Piperazine-piperidine compounds as hepatitis c virus inhibitors
10/31/2013DE59209330C5 Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Benzimidazoles, pharmaceutical compositions containing them and methods for their preparation
10/31/2013DE19719831B4 Verfahren zur Herstellung der beta-Modifikation von Hexanitrohexaazaisowurtzitan A process for the preparation of the beta-modification of hexanitrohexaazaisowurtzitane
10/30/2013EP2657237A1 Novel cyclic amine compound, and process for producing polyurethane resin using same
10/30/2013EP2657233A1 3,5-disubstituted alkynylbenzene compound and salt thereof
10/30/2013EP2655377A1 2-amino-4-arylthiazole compounds as trpa1 antagonists
10/30/2013EP2655376A1 5,6-DIHYDRO-IMIDAZO[1,2-a]PYRAZIN-8-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE)
10/30/2013EP2655375A1 Pyrimidinone derivatives, preparation thereof and pharmaceutical use thereof
10/30/2013EP2655371A1 Pyrazolopiperidine compounds as ccr1 receptor antagonists
10/30/2013EP2655370A1 Compositions and methods for modulating fxr
10/30/2013EP2655358A1 Oxindolopyrimidine as igf1r receptor inhibitors
10/30/2013EP2654421A1 Fused heterocyclic indane carboxamide cgrp receptor antagonists
10/30/2013CN103380132A Phenanthridine macrocyclic hepatitis c serine protease inhibitors
10/30/2013CN103374004A 酰胺类卟啉衍生物及其制备方法 Amides porphyrin derivatives and preparation method
10/30/2013CN103374003A Synthetic method for semi-cucurbituril [6] with 2-imidazolidone and derivatives therefor as unit
10/30/2013CN103374002A Phosphodiesterase-5 inhibitor
10/30/2013CN103374001A Imidazo triazines mTOR (Mammalian Target of Rapamycin) inhibitor
10/30/2013CN103374000A Pyrimido diazepine compound as well as pharmaceutical composition and application thereof
10/30/2013CN103373996A Bicyclic derivatives serving as CRTH2 receptor antagonist
10/30/2013CN103373985A 杂环化合物及其用途 Heterocyclic compounds and their use
10/30/2013CN103373971A Urea compounds serving as protein kinase inhibitors
10/30/2013CN102372719B Pemetrexed methyl ester p-toluenesulfanate crystal form and preparation method thereof
10/30/2013CN102268003B Unsymmetrical poly-substituted porphyrin gold (III) type anticancer compound and preparation method thereof
10/30/2013CN101959890B Pyrrolopyrimidinecarboxamides
10/30/2013CN101374846B Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use
10/29/2013US8569504 Imidazopyridine compound
10/29/2013US8569354 Treatment of cognitive disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof
10/29/2013US8569316 Pyrimido [5,4-D] pyrimidine derivatives for the inhibition of tyrosine kinases
10/29/2013US8569314 Triazolo and tetrazolo pyrimidine derivatives as HNE inhibitors for treating COPD
10/29/2013US8568975 Sorting system for cattle
10/29/2013US8568965 Organic semiconducting material, and film, organic electronic device and infrared dye composition each including said material
10/29/2013US8568694 Nanoparticulate probe for in vivo monitoring of tissue oxygenation
10/29/2013CA2607021C Diaryl-purines, -azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitors for treatment of hiv
10/24/2013WO2013159064A1 Benzothiazol- 6 -yl acetic acid derivatives and their use for treating an hiv infection
10/24/2013WO2013158776A1 Compounds and methods for antiviral treatment
10/24/2013WO2013157583A1 Novel carbapenem compound
10/24/2013WO2013157562A1 Nitrogenated bicyclic aromatic heterocyclic compound
10/24/2013WO2013157495A1 Organic electroluminescence element and production method for organic electroluminescence element
10/24/2013WO2013157021A1 Bicyclic compounds, compositions and medicinal applications thereof
10/24/2013WO2013156772A1 Crystalline forms of (s) -4-amino-n- (1- (4 - chlorophenyl) - 3 - hydroxypropyl) -1- (7h - pyrrolo [2, 3-d] pyrimidi n-4-yl) piperidine-4-carboxamide
10/24/2013WO2013156608A1 Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments
10/24/2013WO2013135671A9 Fungicidal pyrimidine compounds
10/24/2013WO2012125746A9 Tricyclic gyrase inhibitors
1 ... 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 ... 573